C&R Research씨엔알리서치
359090 · KOSDAQ · ₩359090 · 씨엔알리서치
₩2,205▲ ₩30 (1.38%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating margin | −0.7% | 2.1% | 6.1% | 11.3% | 9.7% | 13.5% |
| Net margin | 2.6% | 4.0% | 6.4% | 10.1% | 8.1% | −7.6% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −2.2% | +8.9% | +8.3% | +13.6% | +12.3% | — |
| Operating income growth | −133.2% | −61.9% | −41.8% | +32.4% | −19.0% | — |
| Net income growth | −35.7% | −32.6% | −31.0% | +41.6% | +219.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 3.4% | 5.4% | 8.6% | 14.2% | 11.8% | −10.8% |
| Return on assets | −1.2% | 1.2% | 4.1% | 7.5% | 5.5% | −4.6% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 101.9% | 76.9% | 81.8% | 83.2% | 95.5% | 133.9% |
| Net debt to equity | 3.4% | −4.6% | −15.7% | −13.8% | 2.5% | −18.0% |
| Current ratio | 105.6% | 118.6% | 125.3% | 115.7% | 95.1% | 97.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: C&R Research / 씨엔알리서치 / 359090 / KRX:359090
Source: KRX statistical information